Диссертация (1154515), страница 12
Текст из файла (страница 12)
Baweja, M. Deb // Journal of Ayub MedicalCollege Abottabad, Pakistan. - 2007. - Vol. 19. - P. 39-41.39.Bahalo, S. Detection of some virulence factors of Escherichia coli isolatedfrom UTI isolated of children in Shahrekord Iran by multiplex PCR / S. Bahalo, E.Tajbakhsh, S. Tajbakhsh, M. Momeni, F. Tajbakhsh // Middle East Journal of ScientificResearch.
- 2013. - Vol. 14, № 1. - P. 29-32.40.Barber, A.E. UTIs: Current and emerging management strategies / A.E.Barber, J.P. Norton, A.M. Spivak, M.A. Mulvey // Clinical Infectious Diseases. - 2013.- Vol. 57. - P. 719-724.41.Baskin, L.S. UTI/Pyelonephritis / L.S. Baskin, H. Copp, M. DiSandro, A.Arnhym, A.
Champeau // UCSF Medical Center, Pediatric Urology, San Francisco, CA,USA. - 2013. - P.1-3. Available online from http://www.urology.ucsf.edu42.Battikhi, M.N. Correlation of UTI pathogens, antibiogram and age group inpregnant women / M.N. Battikhi, Q.G. Battikhi // Journal of Microbiology andExperimentation. - 2015. - Vol. 2, Issue 4. - P. 1-6.43.Beytur, A. Oral amoxicillin-clavulanic acid treatment in UTIs caused byESBL-producing organisms / A. Beytur, Y. Yakupogullari, F. Oguz, B.
Otlu, H.Kaysadu // Jundishapur Journal of Microbiology. - 2015. - Vol. 8, № 1. - P. 1-5.44.Biscola, F.T. Determination of adhesin gene sequences in, and biofilmformation by, O157 and non-O157 shiga toxin-producing Escherichia coli strainsisolated from different Sources / F.T. Biscola, C.M. Abe, B.E. Guth // AppliedEnvironmental Microbiology. - 2011. - Vol.
77, № 7. - P. 2201-2208.45.Blango, M.G. Persistence of UPEC in the face of multiple antibiotics /M.G. Blango, M.A. Mulvey // Antimicrobial Agents and Chemotherapy. - 2010. - Vol.54. - P. 1855-1863.7246.Boothe, D.M. Aminoglycosides: Antibacterial agents / D.M. Boothe //Merck Manuals: The Merck Veterinary Manual. New Jersey, USA. - 2012. - P. 1-19.Availableonlinefromhttp://www.merckvetmanual.com/mvm/pharmacology/antibacterial_agents/aminoglycosides.html47.Boyko, E.J. Risk of UTI and ASB among diabetic and nondiabeticpostmenopausal women / E.J.
Boyko, S.D. Fihn, D. Scholes, L. Abraham, B. Monsey //American Journal of Epidemiology. - 2005. - Vol. 161. - P. 557-564.48.Brachman, P.S. Bacterial infections of humans: Epidemiology and control /P.S. Brachman, E. Abrutyn // 4th edition. Springer Science+Business Media, USA.
2009. - P. 543-576.49.Bradford, P.A. ESBLs in the 21st century: Characterization, epidemiology,and detection of this important resistance threat / P.A. Bradford // Clinical MicrobiologyReviews. - 2001. - Vol. 14, № 4. - P. 933-951.50.Brien, K.O. The prevalence of UTI in children under five years oldpresenting with an acute illness in UK general practice / K.O. Brien // Ph.D. Study.Cardiff University, Wales, UK. – 2013. - P.
1-316.51.Briongos-Figuero, L.S. Epidemiology, risk factors, and comorbidity forUTIs caused by ESBL producing Enterobacteria / L.S. Briongos-Figuero, T. GómezTraveso, P. Bachiller-Luque, M.D-G. González, A. Gómez-Nieto // InternationalJournal of Clinical Practice. - 2012. - Vol. 66, № 9. - P. 891-896.52.British Infection Association (BIA). Diagnosis of UTI: Quick referenceguide for primary care // Royal College of General Practitioners (RCGP), UK.
- 2014. P.1-8.Availableonlinefromhttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/323398/UTI_guidelines_with_RCGP_logo.pdf53.Brooks, G.F. Jawetz, Melnick and Adelberg’s Medical Microbiology.Section III: Bacteriology / G.F. Brooks, K.C. Carroll, J.S. Butel, S.A. Morse, T.A.Mietzner // 25th international edition. McGraw-Hill Lange Medical Book, USA. - 2010,- P.
145-370.7354.Bunyan, I.A. Investigation of fimH adhesin among Enterobacter spp.isolates and their role in biofilm formation / I.A. Bunyan, M.S. Abdul-Razzaq, H.O. AlDahmoshi, N.S. Kadhim // International Journal of Pharmaceutical Invention. - 2013. Vol. 3, Issue 1. - P. 1-18.55.Burd, E. A critical appraisal of the role of the clinical microbiologylaboratory in the diagnosis of UTIs / E. Burd, K.S. Kehl // Journal of ClinicalMicrobiology.
- 2011. - Vol. 49, Suppl. 9. - P. S34-S38.56.Burton, D.C. Trends in CAUTIs in adult intensive care units-United States,1990-2007 / D.C. Burton, J.R. Edwards, A. Srinivasan // Infection Control and HospitalEpidemiology. - 2011. - Vol. 32, № 8. - P. 748-756.57.Bush, K. Functional classification scheme for beta-lactamases and itscorrelation with molecular structure / K. Bush, G. Jacoby, A. Medeiros // AntimicrobialAgents and Chemotherapy. - 1995. - № 39.
- Р. 1211-1233.58.Bush, K. New beta-lactamases in gram-negative bacteria: Diversity andimpact on the selection of antimicrobial therapy / K. Bush // Clinical InfectiousDiseases. - 2001. Vol. 32, № 7. - P. 1085-1089.59.Bush, K. ESBLs in North America, 1987-2006 / K. Bush // ClinicalMicrobiology and Infection. - 2008. - Vol. 14, Suppl 1.
- P. 134-143.60.Bush, K. The coming age antibiotic discovery and therapuaticalue / K.Bush // Annals of the New York Academy of Sciences. - 2010. - Vol. 1212. - P. 1-4.61.Butler, C.C. Containing antibiotic resistance: Decreased antibiotic-resistantcoliform UTIs with reduction in antibiotic prescribing by general practices / C.C. Butler,F. Dunstan, M. Heginbothom // British Journal of General Practice. - 2007. - Vol. 57. P. 785-792.62.Caljouw, M.A.A. Predictive factors of UTIs among the oldest old in thegeneral population: A population-based prospective follow-up study / M.A.A.
Caljouw,W.P.J. Elzen, H.J.M. Cools, J. Gussekloo // BMC Medicine. - 2011. - Vol. 9, № 57. - P.1-8.7463.Canton, R. Prevalence and spread of ESBL-producing Enterobacteriaceaein Europe / R. Canton, A. Novais, A. Valverde, E. Machado, L.
Peixe // ClinicalMicrobiology and Infection. - 2008. - Vol. 14, Suppl. 1. - P. 144-153.64.Carattoli, A. Resistance plasmid families in Enterobacteriaceae / A.Carattoli // Antimicrobial Agents and Chemotherapy. - 2009. - Vol. 53, № 6. - P. 22272238.65.Center for Drug Evaluation and Research (CDER). Complicated UTIs:Developing drugs for treatment - Guide for industry // U.S. Department of Health andHuman Services, Food and Drug Administration, USA.
- 2015. - P. 1-17.66.Chakupurakal, R. Urinary tract pathogens and resistance pattern / R.Chakupurakal, M. Ahmed, D.N. Sobithadevi, S. Chinnappan, T. Reynolds // Journal ofClinical Pathology. - 2010. - Vol. 63, № 7. - P. 652-654.67.Chamberlain, N.R. Medical microbiology: The big picture. Section 10:Genitourinary tract, Chapter 34: Infections of the urethra, bladder, kidney, and prostate /N.R. Chamberlain // McGraw Hill Company, USA. - 2009. - P.
341-346.68.Chang, U-I. A comparison of the clinical characteristics of elderly and non-elderly women with community onset, non-obstructive acute pyelonephritis / U-I.Chang, H.W. Kim, Y-S. Noh, S-H. Wie // The Korean Journal of Internal Medicine. 2015. - Vol. 30. - P. 372-383.69.Chenoweth, C.E. UTIs / C.E. Chenoweth, S.
Saint // Infectious DiseaseClinics of North America. - 2011. - Vol. 25, № 1. - P. 103-115.70.Chenoweth, C.E. Preventing CAUTIs in the intensive care unit / C.E.Chenoweth, S. Saint // Critical Care Clinics. - 2013. - Vol. 29, № 1. - P.
19-32.71.Chenoweth, C.E. Diagnosis, management, and prevention of CAUTIs /C.E. Chenoweth, C.V. Gould, S. Saint // Infectious Disease Clinics of North America. 2014. - Vol. 28, № 1. - P. 105-119.72.Clinical and Laboratory Standards Institute (CLSI). Performance standardsfor antimicrobial susceptibility testing // CLSI. 950 West valley road, Suite 2500,Wayne, PA 19087, USA. - 2005. - Supplement M100-S15.
Available online fromwww.clsi.org7573.Clinical and Laboratory Standards Institute (CLSI). Performance standardsfor antimicrobial susceptibility testing // CLSI. 950 West valley road, Suite 2500,Wayne, PA 19087, USA. - 2008. 18th informational supplement. - M100-S18. Availableonline from http://www.clsi.org74.Clinical and Laboratory Standards Institute (CLSI). Urinalysis; Approvedguideline // CLSI.
950 West valley road, Suite 2500, Wayne, PA 19087, USA. - 2009. Vol. 29, № 4. (3rd edition, GP16-A3.) - P. 1-41. Available online fromhttp://www.clsi.org75.CLSI (Clinical and Laboratory Standards Institute). Performance standardsfor antimicrobial susceptibility testing // CLSI, 950 West valley road, Suite 2500,Wayne, PA 19087, USA. - 2012a. - 18th informational supplement. - M100-S18 U.Available online from www.clsi.org76.Clinical and Laboratory Standards Institute (CLSI).
Performance standardsfor antimicrobial susceptibility testing // CLSI, 950 West valley road, Suite 2500,Wayne, PA 19087, USA. - 2012b. 22nd informational supplements update. - M100-S22U. Available online from www.clsi.org77.Coelho, R. Renal and perinephric abscesses: Analysis of 65 cases / R.Coelho, E.D. Schneider-Montero, J.L. Mesquita // World Journal of Surgery. - 2007. Vol. 31. - P. 431-436.78.Colgan, R. Diagnosis and treatment of acute pyelonephritis / R. Colgan //American Academy of Family Physicians. - 2011.
- Vol. 84. - P. 519-526.79.Conway, P.H. Recurrent UTI in children, risk factor and association withprophylactic antimicrobials / P.H. Conway, A. Canaan, T. Zaoutis, B.V. Henry, JAMA.- 2007. - Vol. 298, № 2. - P. 179-86.80.Cornforth, T. Treatment and prevention of UTIs: What you need to knowabout UTI treatments and prevention / Cornforth T // 2014. Available online fromhttp://womenshealth.about.com/cs/bladderhealth/a/UTI_2.htm81.Cosgrove,S.E.Antibioticguidelines2015-2016:Treatmentrecommendations for adults inpatients. Section 6.17: UTI / S.E.
Cosgrove, E. Avdic, K.76Dzintars, J. Smith // The Johns Hopkins Hospital: Antimicrobial Stewardship Program. 2015. - P. 110-114. Available online from http://www.insidehopkinsmedicine.org/amp82.Coyne, K.S. The prevalence of LUTS in the USA, UK, and Sweden:Results from the epidemiology of LUTS study / K.S. Coyne, C.C. Sexton, C.L.Thompson // British Journal of Urology International. - 2009. - Vol. 104.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
